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Abstract
Background: Staphylococcus lugdunensis is an important human pathogen that causes potentially fatal
endocarditis, osteomyelitis and skin and soft tissue infections similar to diseases caused by Staphylococcus aureus.
Nevertheless, in contrast to S. aureus, data on pathogenicity factors of S. lugdunensis is scarce. Two adhesins, a
fibrinogen and a von Willebrand factor binding protein, and a S. lugdunensis synergistic hemolysin (SLUSH) have
been previously described. Moreover, the newly sequenced genome of S. lugdunensis revealed genes of other
putative fibrinogen binding adhesins and hemolysins. The aim of this study was to gain more insight into the
occurrence of genes likely coding for fibrinogen binding adhesins and hemolysins using clinical strains of
S. lugdunensis.
Findings: Most of the putative adhesin genes and hemolysin genes investigated in this study were highly
prevalent, except for the SLUSH gene cluster. In contrast to previous reports, binding to fibrinogen was detected in
29.3% of the S. lugdunensis strains. In most strains, hemolysis on blood agar plates was weak after 24 h and distinct
after 48 h of incubation. The fibrinogen binding and hemolysis phenotypes were also independent of the type of
clinical specimen, from which the isolates were obtained.
Conclusion: In this study we described a pyrrolidonyl arylamidase negative S. lugdunensis isolate. Our data indicate
that a matrix-assisted laser desorption ionisation time-of-flight MS-based identification of S. lugdunensis or species-
specific PCR’s should be performed in favour of pyrrolidonyl arylamidase testing. In contrast to the high occurrence
of putative fibrinogen binding protein genes, 29.3% of the S. lugdunensis strains bound to fibrinogen. Putative
hemolysin genes were also prevalent in most of the S. lugdunensis strains, irrespective of their hemolysis activity on
Columbia blood agar plates. Similar to a previous report, hemolysis after 48 h of incubation is also indicative for S.
lugdunensis. The SLUSH gene cluster was detected in an estimated 50% of the strains, indicating that this locus is
different or non-prevalent in many strains.
Background
Staphylococcus lugdunensis is an important human
pathogen that causes potentially fatal endocarditis,
osteomyelitis and skin and soft tissue infections (SSTI)
similar to diseases caused by S. aureus [1-5]. Fibrinogen
and fibronectin binding adhesins have been discussed as
a pathogenicity factor of S. aureus [6,7]. In S. lugdunen-
sis, two adhesins, the fibrinogen binding protein (Fbl)
[8-10] and the von Willebrand factor binding protein
[11] have been described. A hemolysin, the S. lugdunen-
sis synergistic hemolysin (SLUSH), has also been
described [12,13]. The newly sequenced genome [14] of
S. lugdunensis has revealed an additional gene
(SLGD_01696) that has been annotated as a putative
fibrinogen/fibronectin binding adhesin [15]. Neverthe-
less, data on the prevalence of S. lugdunensis adhesins
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therefore designed primers (Table 1) to characterize the
occurrence of genes coding for putative fibrinogen bind-
ing proteins and supposed hemolysins.
Methods
Bacteria
Fifty-eight clinical strains of S. lugdunensis representing
single patient isolates collected non-consecutively
between 2003 and 2008 were included in this study
(Table 2). This collection represents both urban and
rural settings from the Bochum area, as well as a variety
of community and institutional facilities. S. lugdunenis
was preliminary identified by typical characteristics, such
as odor, and the GPI-card by the Vitek-2 automated
identification system (bioMérieux, Marcy l’Etoile,
France). In addition, the strains were tested for the pre-
sence of ornithine decarboxylase (ODC), an enzyme that
catalyzes the decarboxylation of ornithine to form putres-
cine. Retrospectively, the presence of the pyrrolidonyl
arylamidase (PYR), which hydrolyzes L-pyrrolidonyl-ß-
naphtylamide to L-pyrrolidone and ß-naphtylamide, was
also tested. The S. lugdunensis type strain DSM 4804 was
used as a positive control in both tests. The species diag-
nosis was confirmed using matrix-assisted laser deso-
rption/ionization time-of-flight (MALDI-TOF) mass
spectrometry (MS) [16] and amplification of the tanA
gene, as previously described [17]. A single isolate was
also confirmed by sequencing of the sodA gene, as pre-
viously described [18] Three strains of S. epidermidis (n
=2 )a n dS. hominis (n = 1) initially misidentified as S.
lugdunensis were excluded from this study.
PCR
Strains were molecularly characterized with regard to
genes coding for putative fibrinogen binding proteins,
such as fbl, SLGD 1696 (FbpA), a von Willebrand factor
binding protein gene vwbl, and genes coding for puta-
tive hemolysins [14]. The published sequences were
used [8,9] to design a primer pair for the detection of
the fbl gene (Table 1). The von Willebrand factor bind-
ing protein precursor gene (vwbl) sequences
(AY530288) [11] and SLGD_02429 [14] were used to
design a primer pair for the detection of the vwbl gene.
The annotated putative fibrinogen/fibronectin binding
protein (SLGD_01696) gene sequence [14] was used to
design primers to amplify this gene (Table 1). The
SLUSH gene sequence (U73444.1) [12], the annotated
putative beta-hemolysin (SLGD_00006) gene sequence
[14] and the annotated putative hemolysin III
(SLGD_00847) gene sequence [14] were used to design
primers for the detection of the beta-hemolysin and
hemolysin III genes (Table 1). Genomic DNA of S. lug-
dunensis was extracted using the QIAamp DNA Mini
Kit (Quiagen, Hilden, Germany) suspending the bacteria
in the recommended buffer and addition of 20 μg lysos-
taphin at the lysis step. The master mix contains
dNTP’s (dATP, dCTP, dGTP, and dTTP), 2 units of
pure Taq DNA polymerase and reaction buffer. The
reaction contained also 12.5 pmoles of each primer, 5 μl
of 1:10 diluted template DNA, and water to 25 μl. All
PCRs used an initial denaturation at 94°C for 5 min, fol-
lowed by 35 cycles of an annealing step at 55°C for 30 s,
an elongation step at 72°C for 60 s and denaturation
step at 94°C for 30 s.
Table 1 Primers used for detection
Gene/locus-tag Name Sequence 5’ 3’ Size (bp) Primer
fbl fbl_check_F CGTATTATCCCAAGTAGCAACC 404 This study
fbl_check_R CTTCATCGATTGTCCCAGTAGC
SLGD_01696 FbpA_F GAGATTACTGGACAACAAACG 558 This study
FbpA_R GTATTGTGACGTCGTTTCCTG
SLGD_00006 betahemolysin_F TGGTCAAGGTACAGAAGGTTGGCA 449 This study
betahemolysin_R TATCCCAACTATACGCGTTGCCCT
SLGD_00847 hemolysinIII_F TAATGCTGTTTCGCACGGAGTTGC 407 This study
hemolysinIII_R GACGCCTACCCATCCCATTACAA
SLUSH-cluster slush_donvito_F TTTCGTCTTTGCACACACATTTCCA 977 This study
slush_donvito_R ACAGCACAAAGCCTTAACTATCTCA
SLGD_02429 stlu_vwbl_F TGGCGGGATGATTTGGACGGG 858 This study
vwbl stlu_vwbl_R TCGCCTTCTTGCCCTGATGGT
The previously published fibrinogen binding protein gene (fbl) sequences [8,9], the von Willebrand factor binding protein precursor gene (vwbl) sequences
(AY530288) [18] and SLGD_02429 [13], the putative fibrinogen/fibronectin binding protein (FbpA homologue SLGD_01696) gene sequence [13], the S. lugdunensis
synergistic hemolysin (SLUSH) gene sequence (U73444.1) [11], the S. lugdunensis putative beta-hemolysin (SLGD_00006) gene sequence [11] and the S.
lugdunensis putative hemolysin III (SLGD_00847) gene sequence [11] were used to design primer pairs (This study).
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Page 2 of 8Table 2 Occurrence of putative fibrinogen binding protein and hemolysin genes and their phenotypic correlates
Strains Type of
culture
Species
specific
tanA gene
PYR ODC Clumping
factor
Binding to
solid-phase
fibrinogen
Slidex
Staph
plus
fbl SLGD_01696
FbpA
vwbl Hemolysis on
Columbia blood
agar after 24 h
Hemolysis on
Columbia blood
agar after 48 h
SLGD_00847
hemolysin III
SLGD_00006
beta-
hemolysin
SLUSH
gene
cluster
Stlu 12 blood
culture
++ + + + + + + -- ++ + -
Stlu 17 blood
culture
++ + -- - ++ + - ++ + -
Stlu 20 blood
culture
++ + - - (+) ++ + + + + + + -
Stlu 21 blood
culture
+ + + + +++ + + + + - ++ + +
Stlu 22 blood
culture
++ + -- - ++ + - ++ + +
Stlu 25 blood
culture
++ + -- - ++ + - ++ + +
Stlu 27 blood
culture
++ + + + + + + + - ++ + +
Stlu 28 blood
culture
++ + -- - ++ + --+++
Stlu 30 blood
culture
++ + -- - ++ + - ++ + +
Stlu 32 blood
culture
++ + + + + + + + - ++ + +
Stlu 33 blood
culture
++ + -- - ++ + - ++ + +
Stlu 34 blood
culture
+± * + -- - ++ + - ++ + +
Stlu 39 blood
culture
++ + -- - ++ + - ++ + +
Stlu 50 blood
culture
++ + + + + + + + + - ++ + -
Stlu 53 blood
culture
++ + + + + + + + - ++ + -
Stlu 58 blood
culture
++ + + + + + + + + + + + -
Stlu 2 wound
swab
++ + -- - ++ + - ++ + +
Stlu 3 wound
swab
++ + -- - ++ + - ++ + -
Stlu 5 wound
swab
++ + -- - ++ + - ++ + +
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8Table 2 Occurrence of putative fibrinogen binding protein and hemolysin genes and their phenotypic correlates (Continued)
Stlu 6 wound
swab
+ + + + +++ + + + + - ++ + -
Stlu 7 wound
swab
+ - ++ + + + + +- ++ + -
Stlu 8 wound
swab
+ + + + +++ + + + + - ++ --
Stlu 10 wound
swab
++ + -- - ++ + - ++ + -
Stlu 11 wound
swab
++ + -- - ++ + - ++ + -
Stlu 13 wound
swab
++ + + + (+) ++ + - ++ + +
Stlu 14 wound
swab
++ + -- - ++ + - ++ + -
Stlu 15 wound
swab
++ + + + + + + + - ++ + -
Stlu 16 wound
swab
++ + -- - ++ + - ++ + -
Stlu 23 wound
swab
++ + -- - ++ + - ++ + +
Stlu 24 wound
swab
++ + -- - ++ + - ++ + +
Stlu 26 wound
swab
++ + -- - ++ + --+++
Stlu 29 wound
swab
++ + -- - ++ + - ++ + +
Stlu 35 wound
swab
++ + -- - ++ + - ++ + +
Stlu 36 wound
swab
++ + -- - ++ + - ++ + +
Stlu 37 wound
swab
++ + -- - ++ + + + + + -
Stlu 38 wound
swab
++ + -- - ++ + - ++ - +
Stlu 40 wound
swab
++ + -- - ++ + - ++ + -
Stlu 41 wound
swab
+ + + + +++ + + + + - ++ + -
Stlu 42 wound
swab
++ + + + + + + + - ++ + +
Stlu 43 wound
swab
++ + -- - ++ + - ++ + +
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8Table 2 Occurrence of putative fibrinogen binding protein and hemolysin genes and their phenotypic correlates (Continued)
Stlu 44 wound
swab
++ + -- - ++ + - ++ + -
Stlu 45 wound
swab
++ + + + + + + + + - ++ + +
Stlu 49 wound
swab
++ + -- - ++ + - ++ + -
Stlu 52 wound
swab
++ + + + (+) ++ + - ++ + -
Stlu 54 wound
swab
++ + -- - ++ + - ++ + -
Stlu 55 wound
swab
++ + -- - ++ + + + + + + -
Stlu 57 wound
swab
++ + -- - ++ + - ++ + -
Stlu 59 wound
swab
++ + -- - ++ + - ++ + -
Stlu 60 wound
swab
++ + -- - ++ + - ++ + +
Stlu 61 wound
swab
++ + -- - ++ + --+++
Stlu 9 cathether ++ + -- - ++ + - ++ + -
Stlu 19 cathether ++ + -- - + + + + ++ + + +
Stlu 1 knee
aspirate
++ + + + - ++ + - ++ + +
Stlu 4 knee
aspirate
++ + -- - ++ + - ++ + -
Stlu 18 knee
aspirate
++ + -- - ++ + - ++ + -
Stlu 31 knee
aspirate
+± * + -- - ++ + - ++ + +
Stlu 51 knee
aspirate
++ + -- - ++ + - ++ + + -
Stlu 48 bone
aspirate
++ + -- - ++ + - ++ + -
Fifty-eight clinical strains of S. lugdunensis representing single patient isolates were used in this study. The strains were characterized with regard to putative fibrinogen binding and hemolysin genes and compared
to their phenotypic correlates. Strains with a complete hemolysis were interpreted as positive (+). Strains producing no hemolysis (-) were compared to the negative control S. carnosus TM 300. Strains with a strong
hemolysis after 48 h similar to that of S. aureus Cowan I were interpreted as producing strong hemolysis (++); + = positive; - = negative; (+) = weakly positive; ++ = strongly positive; ±* = test result indeterminate;
pyrrolidonyl arylamidase (PYR); ornithine decarboxylase (ODC).
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8Bacterial adherence to solid-phase fibrinogen
Binding of bacterial cells to immobilized fibrinogen was
previously described [19]. Briefly, the strains were grown
in 4 ml LB-medium for 18 h at 37°C and 100 rpm. A
96-well microtiter plate was coated with 20 μg/ml of
purified fibrinogen (plasminogen, von Willebrand factor
and fibronectin depleted, Enzyme Research Laboratories,
South Bend, USA) in PBS (NaCl 137 mM, KCl 2.7 mM,
Na2HPO4 10 mM, KH2PO4 1.76 mM, pH 7.4) for 18 h
at 4°C. After the solution had been discarded, bovine
serum albumin (2%, w/v, in PBS) was added for 1 h at
37°C. The plates were washed three times with PBS;
then 100 μl of a cell suspension (washed two times in
PBS) of OD600 = 1.0 was added and incubated at room
temperature for 2 h. The wells were washed three times
with PBS and bound cells were fixed with 100 μl formal-
dehyde (25%, v/v) for 30 min at room temperature.
Adherent cells were washed with PBS twice, stained
with crystal violet (0.5%, v/v) for 10 min at room tem-
perature, then washed with PBS again, and dried at
37°C. Absorbance was measured at 550 nm in an ELISA
plate reader (Bio Kinetics Reader EL340, Bio-Tek Instru-
ments). An OD550 value of 0 to 0.06 was interpreted as
negative, 0.07 to 0.15 as intermediately positive (+), 0.15
to 0.3 as positive (++), and >0.3 as strongly positive (++
+). The S. aureus Newman (ATCC 25904) was used as a
positive control and tested strongly positive (+++). A
sample without bacteria was used to determine the
background of this assay.
Clumping factor and latex agglutination
All strains of the S. lugdunensis collection were tested for
agglutination using the commercial S. aureus agglutination
kit Slidex Staph Plus (bioMérieux). For detection of fibri-
nogen clumping a single colony of S. lugdunensis was stir-
red into 50 μl of human citrate plasma and then placed
onto a glass slide. An agglutination within 60 s was inter-
preted as a positive result (Table 2). The S. aureus New-
man (ATCC 25904) was used as a positive control.
Hemolysis on Columbia blood agar plates
Bacteria were plated from the frozen stock cultures onto
Columbia blood agar plates with 5% sheep blood (bio-
Mérieux) and were grown for 24 h and 48 h of incubation
at 37°C. In order to characterize the grade of the beta-
hemolysis induced by S. lugdunensis, the distinct hemoly-
sis was compared to that of an S. carnosus TM 300 and
S. aureus Cowan I. Strains with a complete hemolysis
after 24 h of incubation were interpreted as positive com-
pared to the negative control S. carnosus TM 300 (ATCC
51365). Strains with a hemolysis after 48 h of incubation
similar to that of S. aureus Cowan I (ATCC 12598) were
interpreted as producing strong hemolysis.
Results and Discussion
For S. aureus identification, agglutination-based kits are
often used. These kits usually include antibodies against
fibrinogen binding proteins. It has been described that
some strains of S. lugdunensis react in these agglutina-
tion tests [20]. The correct identification of S. lugdunen-
sis is thus difficult. For the identification of S.
lugdunensis the determination of PYR and ODC has
been described to be sufficient to distinguish S. lugdu-
nensis from other Staphylococci [1,20]. Moreover, a new
species, Staphylococcus pseudolugdunensis, has been
recently described, which was also PYR and ODC posi-
tive [21]. In addition, PYR negative isolates of S. lugdu-
nensis exist. Isolate Stlu 7 (Table 2) was PYR negative
and ODC positive. The identification was confirmed by
MALDI-TOF MS [15], by sequencing of the sodA gene
[17], and also by the detection of the species specific fbl
and tanA g e n e sa sp r e v i o u s l yd e s c r i b e d .I nt w oo t h e r
isolates the PYR test was indeterminate (Table 2). Since
only 94.8% of S. lugdunensis isolates were PYR positive,
an identification strategy based solely on the determina-
tion of the PYR activity could miss an estimated 5% of
the S. lugdunensis isolates. In addition, the fibrinogen
binding gene fbl has been used to establish a S. lugdu-
nensis species-specific PCR [22,23]. In our strain collec-
tion all 58 strains were shown to be fbl positive using a
primer set targeting the A-region of the fbl gene. This
prevalence is similar to the high occurrence of the fbl
previously described [22,23]. All S. lugdunensis strains
were tanA positive (100%) and all were identified as S.
lugdunensis by MALDI-TOF MS (100%). Our data sug-
gest using MALDI-TOF MS technology or detection of
the fbl or tanA gene for the identification of S. lugdu-
nensis and argues against PYR testing for S. lugdunensis
identification.
Fibrinogen binding
Fibrinogen binding ability is usually targeted in S. aur-
eus identification assays such as the Slidex Staph plus
(bioMérieux) and the clumping factor test. It has been
previously described that some strains of S. lugdunensis
could be misidentified as S. aureus using these tests
[20]. In our strains, 17 out of 58 (29.3%) were positive
in the clumping factor test and 17 out of 58 (29.3%)
strains were also positive in the S. aureus identification
kit Slidex Staph plus. Expectedly, all of the strains that
reacted in the clumping factor bound to solid phase
fibrinogen, too. One isolate (Stlu 20) reacted in the Sli-
dex Staph plus test but did not bind to soluble and solid
phase fibrinogen. In another isolate (Stlu 1), binding to
soluble and solid phase fibrinogen was detected but no
agglutination was observed in the Slidex Staph plus test
(Table 2). It has been recently reported that S. aureus
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within an fibrinogen and fibronectin binding adhesin
[24]. In the subgroup of blood culture samples 43.7% of
the strains bound to fibrinogen compared to 26.5% in
the subgroup of wound swabs. Nevertheless, the differ-
ence was statistically not significant as tested by
Fischer’s exact test. Differences in fibrinogen binding
may be explained by different expression of the fibrino-
gen binding proteins. Moreover, the production of an
extra cellular matrix, such as a capsule, which has been
described for S. lugdunensis [2] could also mask the
accession of an adhesin. Similar results has been
described for S. aureus: fibrinogen binding greatly varies
within the strains [25]. In contrast to previous reports,
where 64.7% [26] and 83.7% [27] had been described as
clumping factor positive 29.3% of our strains would be
misidentified as S. aureus in the clumping factor and in
the Slidex Staph plus agglutination test. In all strains,
the genes for the FbpA-homologue (SLGD_01696) and
fbl were present and, therefore we cannot judge if FbpA
is involved in fibrinogen binding. Whether fbl or other
fibrinogen binding proteins react in these assays war-
rants confirmation in future studies. The occurrence of
the vwbl gene was also high (98.2%), similar to a pre-
vious report [18].
No statistical difference was observed in our study
with regard to the type of clinical specimen from which
the isolate was obtained and the fibrinogen binding phe-
notype. A cluster analysis was performed, but also did
not show any correlation of bacterial phenotype and
sample source (data not shown).
Beta-hemolysis
The ability to induce beta-hemolysis on Columbia blood
agar plates (bioMérieux) after 24 h incubation and 48 h
incubation was investigated. The beta-hemolysis of most
strains of S. lugdunensis was weaker compared to S. aur-
eus. Only a hemolysin similar to delta hemolysin of S.
aureus has been described for S. lugdunensis [28]. In
addition, synergistic hemolysins have also been
described [11,12,29]. Similar to findings by others, vir-
tually all strains showed hemolysis after 48 h of incuba-
tion [30]. The hemolysis of red blood cells is an
important pathogenicity factor. Expectedly, the iron
level is an important regulator for hemolysin expression
in many bacteria such as Serratia marcescence [31] and
E. coli [32]. Fifty-four of 58 strains (93.1%) showed no
hemolysis after 24 h. After 48 h three strains also
showed no hemolysis, two strains showed a weak hemo-
lysis, 49 showed distinct hemolysis and four showed a
strong hemolysis, similar to the hemolysis induced by S.
aureus after 48 h. In all strains the gene for hemolysin
III was found. Fifty-six out of 58 strains were also posi-
tive for the beta-hemolysin gene. Interestingly, 30 out of
58 strains (only 51.7%) were negative for the PCR
detecting the SLUSH gene cluster. The initially
described [11] SLUSH gene cluster (SLUSH A to C) was
annotated as methylated-DNA protein-cysteine methyl-
transferase (SLGD_00440), and has an identity of 89% in
the newly sequenced S. lugdunensis genome [13]. The
gene SLGD_00441 was annotated as SLUSH B with an
identity of 92% to the previously described gene cluster
[11]. The following gene SLGD_00442 was also anno-
tated as “SLUSH B” with an identity of 87% to the pre-
viously described gene cluster [11]. Interestingly, three
out of four strains that were strongly positive with
regard to phenotypic hemolysis were negative in the
SLUSH gene specific PCR (Table 2). Notably, SLUSH
gene-derived proteins have also been described as phe-
nol soluble modulins [33]. This indicates that the
SLUSH gene locus could be different or non-prevalent
in an approximately 50% of the strains and therefore the
SLUSH gene cluster and the basis of hemolysis should
be characterized in further detail. No statistical differ-
ence was observed in our study with regard to the type
of clinical specimen from which the isolate was obtained
and the hemolysis phenotype.
Conclusion
I nt h i ss t u d yw ed e s c r i b e daP Y Rn e g a t i v ei s o l a t eo fS.
lugdunensis. Our data indicate that a matrix-assisted
laser desorption ionisation time-of-flight MS-based iden-
tification of S. lugdunensis or species-specific PCR’s,
detecting the fbl or the tanA gene, should be used in
favour of a PYR testing. In addition, this study provides a
first look into the occurrence of putative fibrinogen-bind-
ing proteins and suspected hemolysins of S. lugdunensis
and their phenotypic correlates. The fbl, the FbpA-homo-
logue (SLGD 1696) and the vwbl are highly prevalent in
S. lugdunensis strains. Notably, this high occurrence was
independent of the fibrinogen binding ability of the
strains. In contrast to previous reports only 29.3% of the
strains bound to fibrinogen. Such strains could be misi-
dentified as S. aureus in fibrinogen binding-based aggluti-
nation tests. Genes coding for hemolysins (hemolysin III
[SLGD_00847] and beta-hemolysin [SLGD_00006]) are
also highly prevalent in the strains except for the SLUSH
gene cluster, which was detected in only an approxi-
mately 50% of the strains. This indicates that the SLUSH
gene locus could be different or non-prevalent among
many strains. The fibrinogen binding and hemolysis phe-
notypes were independent of the type of clinical speci-
men from which the isolates were obtained.
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